Biotech Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA January 1, 2025
Biotech CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy January 1, 2025
Biotech ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma December 31, 2024
Biotech Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes December 31, 2024
Biotech IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors December 30, 2024
Biotech Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock December 28, 2024
Biotech FireflySci Inc. Announces Price Increase in Response to Proposed Import Tariffs December 27, 2024